Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07685821 · ClinicalTrials.gov registry record · NA
In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment
A NA study, sponsored by Sofwave Medical.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07685821: Active NA study, sponsored by Sofwave Medical.
NCT07685821 is a NA study that is active but no longer recruiting, run by Sofwave Medical. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07685821, a NA study, is active but no longer recruiting, sponsored by Sofwave Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Open-label, non-randomized single-arm prospective, single-center, self-controlled clinical study.
Primary Outcome
Evaluate the biological responses of tissue inflammation, proliferation and remodeling via fibroblast stimulation following SofWave single treatment. Tissue biological responses will be correlated with the patients' skin laxity and global aesthetic improvement.
Interventions
- DEVICE Sofwave
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-12-22 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT07685821 still lists
NCT07685821 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Sofwave is the first listed.
NCT07685821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07685821 about?
NCT07685821 is a clinical study titled "In Vivo Study to Evaluate Tissue Remodeling Via Fibroblast Stimulation Following a Single SofWave Treatment". Open-label, non-randomized single-arm prospective, single-center, self-controlled clinical study.
What is the current status of trial NCT07685821?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-12-22. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07685821?
The interventions under investigation include: Sofwave (DEVICE).
Who is sponsoring clinical trial NCT07685821?
This trial is sponsored by Sofwave Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07685821's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI